---
title: "Henlius Biotech Secures Regulatory Approval to Begin Human Trials of Tumor Drugs"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/278370735.md"
description: "Henlius Biotech Secures Regulatory Approval to Begin Human Trials of Tumor Drugs"
datetime: "2026-03-09T10:17:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278370735.md)
  - [en](https://longbridge.com/en/news/278370735.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278370735.md)
---

# Henlius Biotech Secures Regulatory Approval to Begin Human Trials of Tumor Drugs



### Related Stocks

- [02696.HK](https://longbridge.com/en/quote/02696.HK.md)

## Related News & Research

- [Henlius Biotech Doses First Patient in Breast Cancer Drug Study](https://longbridge.com/en/news/282326155.md)
- [Henlius Wins Key EMA Backing for Cancer Drug Serplulimab in Europe](https://longbridge.com/en/news/280997570.md)
- [Sino Biopharmaceutical Unit Enrolls First Patient in Gastric Cancer Drug Trial](https://longbridge.com/en/news/282827241.md)
- [Laekna Says Cancer Drug Meets Progression-free Survival Goal in Phase 3 Trial](https://longbridge.com/en/news/282783180.md)
- [RemeGen Drug Approved For Cancer Indication](https://longbridge.com/en/news/282478668.md)